Keep up with the latest trends and applications of AI in healthcare from the experts at AllazoHealth. Find best practices, tools, and breakthroughs in using artificial intelligence to drive meaningful engagement and outcomes for patient support programs and pharmaceutical marketing.
Over the past decade, treatment in a variety of cancers, particularly breast cancer, chronic myelogenous leukemia, and non-small cell lung cancer, has switched from intermittent intravenous therapy to self-administered targeted oral anticancer medications (OAMs). There…
Read more
As the days tick down to the inauguration of President-elect Joseph Biden and Vice President-elect Kamala Harris, what will be the priorities of the new administration when it comes to U.S. healthcare? Let’s take a…
Read more
How recognizing the unique characteristics of each patient optimizes resources and maximizes impact Medication non-adherence is an age-old problem that pharmaceutical companies have been grappling with for decades. According to industry research, the global pharmaceutical industry loses…
Read more
2020 was dominated by the COVID-19 pandemic, and it will continue to dominate healthcare conversations this year. Looking back, how did the pandemic affect medication adherence? And what lessons were learned? Patient concerns about ability…
Read more
AllazoHealth CEO Clifford Jones and Chief Operating Officer William Grambley recently answered questions about patient intervention data: what it is, how clients employ it, and how AllazoHealth uses this data to accurately predict individual patient…
Read more
Medication non-adherence continues to be one of the most widespread issues faced by the pharmaceutical industry. According to the U.S. Centers for Disease Control, approximately 50 percent of people with chronic illnesses stop taking their…
Read more
There are a lot of companies that claim they offer solutions that are powered by artificial intelligence (AI) and/or machine learning. But what exactly does that mean? AI and machine learning Artificial intelligence is a…
Read more
Produced by MM+M and sponsored by AllazoHealth, this free special report offers a deep dive into how recent innovations in behavioral marketing and economics empower pharma marketers. You’ll learn about how behavioral insights shape strategy…
Read more
Barriers to medication adherence can take the form of social determinants such as housing, employment and access to pharmacies – and systemic barriers such as pre-approvals, multiple prescriptions and affordability. But psychological barriers also play…
Read more
Pharmaceutical companies have aspired to make medication adherence programs more effective for years. A report from Credit Suisse shows that increased adherence could substantially increase revenue from 2020–2026 for leading pharma companies such as Merck,…
Read more